Featured Rich Listers: Douglas family

Jeff Douglas is forecasting a significant rise in revenue in the 2026 financial year off the back of some new product releases and an expected lift in sales to the US, depending on what happens with tariffs on NZ exports.

Category: Make & Sell

$650 million

See all profiles, rankings and feature articles on The NBR List 2025 home page.

Douglas Pharmaceuticals managing director Jeff Douglas is keen on a cut to the corporate tax rate to encourage more business investment.

Finance Minister Nicola Willis floated the idea

Want to read more? It's easy.

Choose your subscription

Already have an account? Login

Smartphone Only Subscription

NZ$29.95 / monthly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Annual Subscription

NZ$299.00 / yearly

Yearly Premium Online Subscription

NZ$499.00 / yearly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$999.00 / yearly

Individual

Group membership

NBR Marketplace

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).

View terms and conditions.

Fiona Rotherham Wed, 06 Aug 2025

Contact the Writer: fiona@nbr.co.nz

News tip? Question? Typo? Let us know: editor@nbr.co.nz

Categories

Analysis

Featured